Regulatory Perspective of Complementary Medicines in Australia

We are happy you are interested in the Freyr’s Webinar Series (FWS). Here is an archived version of the recently concluded webinar ‘ Regulatory Perspective of Complementary Medicines in Australia’ held on July 27, 2023, so you can peruse it at your convenience.

Webinar Key Talking Points

Our in-house Regulatory experts – Kamalakar Deevi and Malgorzata Wojciechowska, shared their extensive knowledge of:

• Complementary Medicines Regulatory Structure in Australia
• Launch of Complementary Medicines Through Listing (L-process) or Registration (R- process)
• Good Manufacturing Practices (GMP) Requirements for Complementary Medicines
• Permissible Ingredients and TGA-Assessed Claims
• Information for Sponsors to Market Complementary Medicines in Australia

Freyr is committed to organizing more on-demand Webinar sessions related to the Regulatory aspects of Life sciences with frequent regularity. We presume that you would like to be a part of it. If you are interested, please let us know so we can inform you about our next session.